Previous Article | Next Article ![]()
Journal of Virology, November 1999, p. 9237-9246, Vol. 73, No. 11
Department of Viral Infection1 and
Department of Infectious Diseases,
Received 11 May 1999/Accepted 9 August 1999
In paramyxovirus transcription, viral RNA polymerase synthesizes
each monocistronic mRNA by recognizing the gene start (S) and end (E)
signals flanking each gene. These signal sequences are well conserved
in the virus family; nevertheless, they do exhibit some variations even
within a virus species. In Sendai virus (SeV) Z strain, the E signals
are identical for all six genes but there are four (N, P/M/HN, F, and
L) different S signals with one or two nucleotide variations. The
significance of these variations for in vitro and in vivo replication
has been unknown. We addressed this issue by SeV reverse genetics. The
luciferase gene was placed between the N and P gene so that recombinant
SeVs expressed luciferase under the control of each of the four
different S signals. The S signal for the F gene was found to drive a
lower level of transcription than that of the other three, which
exhibited comparable reinitiation capacities. The polar attenuation of
SeV transcription thus appeared to be not linear but biphasic. Then, a
mutant SeV whose F gene S signal was replaced with that used for the P,
M, and HN genes was created, and its replication capability was
examined. The mutant produced a larger amount of F protein and
downstream gene-encoded proteins and replicated faster than wild-type
SeV in cultured cells and in embryonated eggs. Compared with the wild
type, the mutant virus also replicated faster in mice and was more
virulent, requiring a dose 20 times lower to kill 50% of mice. On the
other hand, the unique F start sequence as well as the other start
sequences are perfectly conserved in all SeV isolates sequenced to
date, including highly virulent fresh isolates as well as egg-adapted
strains, with a virulence several magnitudes lower than that of the
fresh isolates. This moderation of transcription at the F gene may
therefore be relevant to viral fitness in nature.
Sendai virus (SeV) is an enveloped
virus, with a nonsegmented negative-strand RNA genome of 15,384 bases,
and belongs to the genus Respirovirus in the family
Paramyxoviridae. The SeV genome is organized starting with
the short 3' leader region, followed by six genes encoding the N
(nucleocapsid), P (phospho-), M (matrix), F (fusion), HN
(hemagglutinin-neuraminidase), and L (large) proteins, and ending with
a short 5' trailer region. In addition to the P protein, the second
gene expresses the accessory V and C proteins by a process known as
cotranscriptional editing to insert a single nontemplated G residue
(34, 35, 41, 42) and by alternative translational
initiations, respectively (10, 28). The genome is tightly
associated with the N protein, forming the helical ribonucleoprotein
complex (RNP). This RNP, but not the naked RNA, is the template for
both transcription and replication (30). There is only a
single promoter at the 3' end of the viral RNA polymerase, comprising
the P and L proteins (11). By recognizing the short
conserved end (E) and restart (S) signals at each gene boundary, the
polymerase gives rise to leader RNA and each mRNA (7). There
is a trinucleotide intergenic sequence between the E and S signals,
which is not transcribed (9, 31). Since the reinitiation
efficiency of transcription at each gene boundary is high but not
perfect, the transcripts from the downstream genes are less abundant
than those from the upstream genes. Therefore, each mRNA is not
synthesized in equimolar quantities in infected cells but there is
polar attenuation of transcription toward the 5' end (7, 17,
30).
After translation of the mRNAs and accumulation of translation
products, genome replication takes place. Here, the same viral RNA
polymerase replicates the same RNP template, but now it somehow ignores
the successive E and S signals for mRNAs and generates a full-length
antigenomic positive-sense RNP (30). The polymerase enters
the promoter at the 3' end of the positive-sense RNP to generate the
genomic negative-sense RNP, which serves as the template for the next
round of transcription and replication.
The E sequence (3'-AUUCUUUUUU-5' in the negative-sense
genome) is completely conserved among the six genes in the SeV genome. Five U residues in the latter half allow polymerase slippage, generating poly(A). In contrast, the S signals are variable and are
generalized as 3'-UCCCWVUUWC-5' (9). They are
UCCCACUUUC for the P, M, and HN genes, UCCCAgUUUC
for the N gene, UCCCuaUUUC for the F gene, and
UCCCACUUaC for the L gene. Identical differences are seen in
all SeV strains sequenced to date, regardless of differences in
isolation procedure, passage history, and virulence for mice, the
natural host, suggesting that the variations are locus specific (Table
1). Thus, it has to be defined whether
these variations have any significance for SeV replication and
pathogenesis. To address this issue, we took advantage of SeV reverse
genetics, which has been previously employed for identifying the gene
functions and their contributions to viral pathogenesis (21, 22,
26, 32, 33, 37).
In this study, the firefly luciferase gene fused with the novel
upstream E and S signals was inserted in the downstream noncoding region of the N gene. The S signals were changed exactly according to
the four naturally occurring variations described above. In the
recombinant viruses, the N mRNA transcription starts by its own S
signal and terminates by the synthetic E signal within the inserted
reporter sequence. Reporter gene expression, which was driven by each
of the different S signals, was quantitated and compared each to the
other. Thus, assessed reinitiation activity was remarkably lower for
the natural S signal of the F gene than for those of the other three.
Furthermore, when the natural S signal for the F gene was converted to
that with a higher reinitiation activity, the recombinant virus was
found to replicate faster, be more cytopathic in cell culture, and be
more virulent for mice. SeV replication capability thus appeared to be
moderated by a modification of the F gene S signal, and the
significance of such moderation is discussed.
Cell cultures and virus infection.
The monkey
kidney-derived cell lines LLCMK2 and CV1, were grown in minimal
essential medium (MEM) supplemented with 10% fetal bovine serum at
37°C. Monolayer cultures of these cells were infected with the mutant
viruses recovered from cDNAs at an input multiplicity of infection
(MOI) of 10 PFU/cell unless otherwise noted and maintained in
serum-free MEM. The wild-type SeV (Z strain) recovered from the cDNA
(20) was used as a control.
Creation of an insertion site after the N ORF.
The plasmid
pSeV(+) contained a cDNA copy of the full-length SeV antigenome
(20) and was used as the starting material for plasmid
construction. Eighteen nucleotides (gagggcccgcggccgcga) containing the NotI restriction site were inserted
between nucleotides 1698 and 1699 at the 3' end of SeV genome which was
located within the 5' noncoding (in the negative sense) region of the N
gene as shown in Fig. 1 (38).
For the insertion, we used site-directed mutagenesis by a PCR-mediated
overlap primer extension method (16) essentially according
to our previous report (12). Briefly, two primers (NmF,
5'-gagggcccgcggccgcga1699TACGAGGCTTCAAGGTACTT1718-3',
and NmR,
5'-tcgcggccgcgggccctc1698TGATCCTAGATTCCTCCTAC1670-3')
with overlapping 18-nucleotide ends and two outer primers (OP1,
5'-61CAAAGTATCCACCACCCTGAGGAGCAGGTTCCAGACCCTTTGCTTTGC105-3',
and OP2,
5'-2467TTAAGTTGGTVAGTGACTC2449-3')
were synthesized. The first PCRs were performed with the OP1/NmF
and the OP2/NmF primer pairs, using pSeV(+) as a template to gave rise
to 1.6- and 0.8-kDa fragments, respectively. The second PCR was then
performed with the OP1/OP2 primer pair, using the purified 1.6- and
0.8-kDa fragments to generate a single 2.4-kDa fragment with the 18 nucleotides. The 2.4-kDa fragment was purified and digested with
SphI and SalI. Plasmid pSeV(+) was cut at
positions 610 and 2070 on the SeV genome by these enzymes. The sequence of the resulting 1.47-kDa fragment was verified by sequencing on an
AFLII automated DNA sequencer (Pharmacia, Uppsala, Sweden) and replaced
with the same fragment of parental pSeV(+), thus generating pSeV18c(+),
containing a unique restriction site after the N open reading frame
(ORF) (Fig. 1).
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Sendai Virus Gene Start Signals Are Not Equivalent in
Reinitiation Capacity: Moderation at the Fusion Protein Gene
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Gene start sequences of various SeV strains with database
accession numbers
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (16K):
[in a new window]
FIG. 1.
Construction of plasmid pSeV18c(+) and insertion of the
luciferase gene into the downstream region of the N ORF. An
18-nucleotide-fragment designed to contain a NotI site was
inserted between nucleotides 1698 and 1699 from the 3' end
(38) of the SeV genome in pSeV(+) by site-directed
mutagenesis. The resulting plasmid encoding the SeV antigenome with the
18-nucleotide insertion was named pSeV18c(+). The ORF of the luciferase
gene was PCR amplified with four sets of NotI-tagged primers
(ESn/NotLr, ESp/NotLr, ESf/NotLr, and ESl/NotLr) from the template
plasmid, pHvLuc-RT4 (20), to generate the fragments
containing the conserved E signal and each of the different natural S
signals placed at the head of the luciferase gene. These amplified
fragments were digested with NotI and introduced into the
same site of pSeV18c(+). The resulting plasmids, named pSeV(+)SnLuc,
pSeV(+)SpLuc, pSeV(+)SfLuc, and pSeV(+)SlLuc, were used to recover the
recombinants SeV/SnLuc, SeV/SpLuc, SeV/SfLuc, and SeV/SlLuc,
respectively.
Insertion of the luciferase gene with various S elements into
pSeV18c(+).
The luciferase gene from the firefly Photinus
pyralis derived from pHVlucRT4(
) (20) was amplified
by PCR with the following four primer pairs corresponding to the four
different S sequences: ESp,
5'-TTgcggccgcGTAAGAAAAACTTAGGGTGAAAGTTCACTTCACGATGGAAGACGGCAAAAACAT-3'; ESn,
5'-TTgcggccgcGTAAGAAAAACTTAGGGTCAAAGTTCACTTCACGATGGAAGACGGCAAAAACAT-3'; ESf,
5'-TTgcggccgcGTAAGAAAAACTTAGGGATAAAGTTCACTTCACGATGGAAGACGGCAAAAACAT-3'; and ESl,
5'-TTgcggccgcGTAAGAAAAACTTAGGGTGAATGTTCACTTCACGATGGAAGACGGCAAAAACAT-3' and one common reverse primer NotLr,
5'-TCgcggccgcTATTACAATTTGGACTTTCCG-3'. Underlined are a new
set of SeV E and S signals connected to the conserved intergenic
trinucleotide; the lowercase letters represent the NotI
restriction site. The boldface letters represent each unique nucleotide
in the S signals. The 1.7-kDa fragments amplified with these primer
pairs were purified, digested with NotI, and directly
introduced into the NotI site of pSeV18c(+) (Fig.
1). The final constructs were named
pSeV(+)SpLuc, pSeV(+)SnLuc, pSeV(+)SfLuc, and pSeV(+)SlLuc,
respectively.
|
Mutagenesis to modify the S signal of the F gene in pSeV(+). A two-nucleotide exchange was performed on the S sequence of the F gene by two successive steps. At the first step, pSeV(+) was cleaved by BanIII at SeV positions 2088 and 5333 in pSeV(+) and the resulting 3.4-kDa fragment was recloned into the same restriction site of pBluescrit KS(+) (Stratagene, La Jolla, Calif.) to make pB/BanIII. Then, site-directed mutagenesis by a PCR-mediated overlap primer extension method (16) was performed as described above, using two inner primers (mGS1F, 5'-4810CTTAGGGTGAAAGTCCCTTGT4830-3', and mGS1R, 5'-4830ACAAGGGACTTTCACCCTAAG4810-3') and two outer primers (M1F, 5'-3931TACCCATAGGTGTGGCCAAAT3951-3', and T7, 5'-TAATACGACTCACTATAGGGC-3'). Underlined are the mutagenesis points. The first PCR was performed with the primer pairs MF1/mGS1R and T7/mGS1F, using pB/BanIII as a template, and yielded 0.9- and 0.6-kDa fragments, respectively. The second PCR was then performed with the M1F/T7 primer pair using these two purified fragments, generating a single 1.5-kDa fragment with the two nucleotide mutations. This fragment was purified and digested with BanIII and recloned into the same restriction site of pSeV(+) to make pSeV(+)mGSf. The authenticity of sequences to be cloned was verified by nucleotide sequencing.
Virus recovery from cDNAs.
Viruses were recovered from cDNAs
essentially according to the previously described procedures
(20). Briefly, 2 × 106 LLCMK2 cells in
6-cm-diameter plates were infected with vaccinia virus (VV), vTF7-3, a
gift of B. Moss (5), at an MOI of 2 PFU/cell. Then, 10 µg
of the parental or mutated pSeV(+) and the plasmids encoding
trans-acting proteins, pGEM-N (4 µg), pGEM-P or the
mutated pGEM-P (see above) (2 µg), and pGEM-L (4 µg) were
transfected simultaneously with the aid of Lipofectin reagent (DOTAP;
Boehringer-Mannheim, Mannheim, Germany). The cells were maintained in
serum-free MEM in the presence of 40 µg/ml of araC
(1-
-D-arabinofuranosylcytosine) and 100 µg/ml of
rifampin to minimize VV cytopathogenicity and thereby maximize the
recovery rate (20). Forty hours after transfection, cells
were harvested, disrupted by three cycles of freezing and thawing, and
inoculated into 10-day-old embryonated hen eggs. After 3 days of
incubation, the allantoic fluid was harvested. The titers of recovered
viruses were expressed in hemagglutination units and PFU/milliliter as
described previously (20). The helper VV contaminating the
allantoic fluid of the eggs containing 108 to
109 PFU/ml of the recovered SeVs was eliminated by the
second propagation in eggs at a dilution of 10
7. This
second passage of fluids, stored at
80°C, was used as the seed
virus for all experiments.
Luciferase assay. The expression of luciferase activity from SeV was studied in 5 × 105 CV1 cells/well in 6-well plates at input multiplicities of from 1 to 300 PFU per cell. Under the single-cycle growth conditions, cells were harvested at 0, 6, 14, 20, and 26 h postinfection. Primary virus transcription was studied by incubating infected cells with 100 µg/ml of cycloheximide (Sigma, St. Louis, Mo.) for 12 h, followed by incubation without cycloheximide for an additional 0, 2, and 4 h. The luciferase activity of harvested cells was measured by a luciferase assay kit (Promega, Madison, Wis.) with a luminometer (Luminos CT-9000D, Dia-Iatron, Tokyo, Japan) as described before (12, 20).
RNA extraction and Northern hybridization. RNAs were extracted from the cells using TRIzol (Gibco BRL) or from culture supernatants and egg allantoic fluids using TRIzol/LS (Gibco BRL). For Northern hybridization, the RNAs were ethanol precipitated, dissolved in formamide-formaldehyde solution, electrophoresed in 0.9% agarose-formamide-MOPS gels, and capillary transferred onto Hibond-N filters (Amersham, Buckinghamshire, United Kingdom). They were probed with 32P-labeled probes made by the multiprime labeling kit (Amersham). For the luciferase probe, the NarI/HincII (1,270-bp) fragment was purified from pHvlucRT4 (20). For the SeV N probe, the PstI/PvuI (1,189-bp) fragment was purified from pGEM-N. For the P probe, 792 bp of the SmaI/SmaI fragment was purified from pGEM-P. For the M, F, HN, and L probes, the NdeI/NdeI (878-bp), BamHI/BamHI (902-bp), ScaI/ScaI (1,108-bp), and BamHI/BamHI (1,654-bp) fragments, respectively, were purified from pSeV(+).
Western blotting. CV1 cells (2 × 105) grown in 6-well plates were infected at an MOI of 10 PFU per cell with the wild type or with SeV/mSf and harvested at various times postinfection. The cell pellets were lysed and run in sodium dodecyl sulfate-12.5% polyacrylamide gels (29) and immunoprobed with anti-SeV rabbit serum as described previously (19, 20).
Virus passages in eggs and virus detection.
The wild-type
SRV and SeV/mSf, which was a mutant virus recovered from the plasmid
pSeV(+)mGSf, were coinoculated into two embryonated hen eggs with the
respective doses of 104 PFU/egg or both 104 and
102 PFU/egg. Every 3 days postinoculation, the allantoic
fluids were harvested and after dilution of 10
6,
reinoculated into new eggs. These reinoculations were successively repeated 10 times. The viruses grown in the allantoic fluids were semiquantitatively measured by reverse transcription-PCR (RT-PCR) with
specific primer pairs. The RNA was extracted from 25 µl of each
allantoic fluid, reverse transcribed with primer HvM
(5'-4448TTTTCTCACTTGGGTTAATC4467-3')
at 50°C for 30 min, using Superscript II (Gibco BRL), and heat
denatured at 94°C for 2 min. The cDNAs were amplified with primers
HvM and GS2WR
(5'-4836GCACTCACAAGGGACTTTCA4817-3')
for wild-type SeV and with primers HvM and GS2MR
(5'-4836GCACTCACAAGGGACTTTat4817-3')
for SeV/mSf as described previously (21, 28). The
lowercase letters represent the mutated dinucleotides. The specific
products were analyzed by electrophoresis in agarose gels as described above.
Infection of mice. Specific-pathogen-free, 3-week-old BALB/c and 4-week-old BALB/c (nu/nu) male mice were purchased from Charles River Laboratories. These mice were infected intranasally with 104, 105, 106, 107, or 108 PFU/mouse of the wild type or SeV/mSf under mild anesthetization with ether (23). Their body weights were individually measured every day up to 14 days. At 0, 1, 3, 5, 7, and 9 days postinfection, three mice in each group were sacrificed and the virus titers in the lungs were measured for BALB/c and BALB/c (nu/nu) mice inoculated with 104 PFU. Consolidation in the lungs was scored at the same time. The consolidation scores are expressed as follows: 0, no visible lesions or atrophy; 1, less than 25% of follicles affected; 2, 25 to 50% of follicles affected; 3, 50 to 75% of follicles affected; 4, more than 75% of follicles affected. When the mice died, one point was added for a score of 5.
| |
RESULTS |
|---|
|
|
|---|
Recovery of recombinant viruses expressing the luciferase gene under control of different S signals and their characterization. To insert the luciferase gene with a synthetic set of E and S signals, a unique NotI site was created downstream of the N ORF within the N gene essentially according to our previous work for the insertion of the same gene in the upstream noncoding region of the N ORF (12). In the present case, insertion of an 18-nucleotide (GAGGGCCCGCGGCCGCGA) stretch containing a NotI restriction site was not deleterious for virus rescue, with the recovery of a recombinant virus possessing full infectivity and replication capability similar to those recovered from the parental pSeV(+) (data not shown). Then, the luciferase genes fused to each of the four S sequences (Sn, Sp, Sf, and Sl) were inserted into the NotI site of the cDNA plasmid, pSeV18c(+) (Fig. 1). In all attempts, recombinant viruses were recovered. They were named SeV/SpLuc, SeV/SnLuc, SeV/SfLuc, and SeV/SlLuc, respectively, according to the S signals used.
The recombinant viruses were found to replicate more slowly than the wild type in CV1 cells (Fig. 2A), probably because of accommodation of an extra gene as long as 1,728 nucleotides (12). Among the four recombinants, SeV/SfLuc was still more attenuated because of reduced reinitiation activity at this particular S sequence (see below). Luciferase activities expressed from the recombinant SeVs were compared with each other. In all cases, the activities increased as infection proceeded (Fig. 2B) and their levels correlated well with those of luciferase mRNAs, which were identified as monocistronic transcripts by Northern hybridization (data not shown). These data unequivocally demonstrated that the synthetic E and S signals inserted just before the luciferase ORF were correctly recognized by the viral RNA polymerase. Remarkably, there were striking differences in luciferase activities, which appeared to be brought about by the S signal variations. The highest activity was obtained with SeV/SlLuc, and the lowest activity was obtained with SeV/SfLuc at 26 h postinfection (Fig. 2B). SeV/SpLuc and SeV/SnLuc had slightly lower activities than SeV/SlLuc at 26 h postinfection. However, this was not seen at 14 and 20 h postinfection. Thus, the reinitiation capacities of Sp, Sn, and Sl were regarded as comparable. To see whether the above differences were primarily brought about at the level of transcription but not as part of the replication process, cells infected with the recombinants were incubated in the presence of cycloheximide, which inhibits protein synthesis and hence blocks viral replication requiring de novo viral protein synthesis. Under these conditions, only primary virus transcription catalyzed by the virion-associated RNA polymerase is allowed. After primary transcription and accumulation of viral mRNAs, cycloheximide was washed out from the culture. Cells were either lysed immediately to prepare the viral RNA (Fig. 2C) or incubated for an additional 0, 2, or 4 h to allow protein synthesis for measuring luciferase activities (Fig. 2D). The activities increased as the incubation period after cycloheximide removal was prolonged; SeV/SfLuc was again significantly lower than the other three in luciferase expression. The amounts of luciferase mRNA in each of the virus-infected cell groups correlated well with the activities of luciferase (Fig. 2C). The luciferase activities at 4 h of incubation were normalized to that of SeV/SpLuc, as this type of S signal is shared with three of the six genes. SeV/SnLuc and SeV/SlLuc activities were 0.86 and 1.19, respectively, and thus nearly comparable to SeV/SpLuc. In contrast, SeV/SfLuc reached only 0.24 of the control (Fig. 2D). These results strongly suggested that the signal used for F gene expression possessed a lower reinitiation potential than the other S signals.Creation of an SeV mutant with an altered S signal for the F gene. The results described above suggested that there was a down-regulation of transcription at the F gene in the natural genome context of SeV. To substantiate this, we next created the mutant SeV/mSf, whose S signal for the F gene was replaced with that for the P/M/HN gene, and compared its replication with that of the wild type. SeV/mSf was found to grow faster than the wild type in CV1 cells (Fig. 3A). Cytopathogenicity, as manifested by cell rounding and cell detaching in the absence of trypsin and by cell fusion in the presence of exogenous trypsin to proteolytically activate the F glycoprotein, was greater for the mutant than for the wild type (Fig. 3B).
|
Expression of SeV/mSf genes. The mRNA levels in CV1 cells infected with the wild-type and mutant viruses were compared by Northern blotting at various times postinfection. As shown in Fig. 4A, the F and L transcripts from SeV/mSf were detected earlier and reached remarkably higher levels than those from the wild-type infection. The P and N transcripts were also detected earlier in SeV/mSf infection, although the peak levels were comparable. Accordingly, the levels of F0 protein in the former were significantly higher than in the latter (Fig. 4B) at any time point throughout infection. The downstream gene products, HN and L, were not well resolved in this experiment. Enhanced expression of the F and L genes, but not of the N and P genes, was also clearly seen under the conditions of blocking de novo protein synthesis by cycloheximide (Fig. 4C). These results again unequivocally demonstrated that the S signal naturally occurring in F gene transcription possesses a lower reinitiation/promoter activity and hence down-regulates expression of F and downstream genes. Probably because of enhanced L gene expression, the virion RNA levels were higher for the mutant than for the wild type throughout infection (Fig. 4A). Earlier detection of mRNAs in mutant-infected cells, as demonstrated in Fig. 4A, might be also due to increased L gene expression.
|
Successive copassages of the wild type and SeV/mSf in embryonated hen eggs. Although wild-type SeV replicated more slowly than SeV/mSf in CV1 cells as shown in Fig. 2A, the possibility still remained that the naturally occurring down-regulation of transcription for the F and downstream genes would be advantageous for the persistence of SeV in the host, chicken embryos, than the artificially introduced up-regulation. We thus examined whether either the wild type or SeV/mSf would compete each other out during copassages of the two viruses in eggs. Coinfection was initiated with 104 PFU/egg of the two viruses or with 102 PFU/egg of the wild type and 104 PFU/egg of the mutant. At each inoculation up to the 10th passage, specific RT-PCR was performed to amplify either of the two viral genomes isolated from virions in the allantoic fluids, as shown in Fig. 5A. It was found that the wild-type genome was competed out by the eighth passage in the case of a 104-104 initial inoculation and by the fifth passage following a 102-106 initial inoculation (Fig. 5B). In control experiments, each virus was individually passaged and the genome sequences were determined. The results indicated that both viral genomes were stably maintained during 10 successive passages without any nucleotide change in the regions sequenced. These data indicated that the naturally occurring F gene S signal conferred no replication advantage on SeV at least in ovo.
|
Pathogenicity of wild-type SeV and SeV/mSf for mice. The final issue addressed in this work was whether the mutant SeV/mSf would replicate faster and be more pathogenic than the wild type in mice, the natural host, for which much more complex conditions exist than for cultured cells or eggs. Infections of BALB/c mice with the wild-type and mutant viruses were initiated intranasally at doses of 104, 105, 106, 107, and 108 PFU/mouse (Fig. 6). The mouse body weight gain was strongly disturbed by inoculations of 107 PFU of both viruses. All mice were killed by either virus at similar days postinfection. At 106 PFU, significant differences were found between the two viruses. Infection with SeV/mSf more strongly affected body weight gain than infection with the wild type. The former killed all mice, while the latter killed only one and allowed the remaining to regain the weight. At 105 PFU, all mice infected with the wild type showed a pattern of weight gain nearly comparable to that of mock-infected mice and survived, while those infected with the mutant did not. Thus, SeV/mSf was clearly more virulent than the wild type. The difference in virulence was quantitated by determining the 50% lethal dose (LD50); the LD50 was 1.78 × 106 PFU for the wild type and 7.94 × 104 PFU for the mutant (Table 2). The mutant virus was thus 22 times more virulent than the wild type for the BALB/c strain. These results suggested that the naturally occurring F gene S signal attenuated SeV to some extent so that infected mice survive longer.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
All nonsegmented negative-strand RNA genomes possess semiconserved, similarly sized S and E signals. Conservation of the sequences of these signals is extensively high within a viral genus and within a family and is extremely high among genes of a given virus species (4). However, there are some variations even within a virus species. In the case of the SeV S signal, there are four variations (9). Remarkably, these variations are fixed perfectly at the same respective genes of all strains, including fresh isolates, which are highly virulent for the natural host, rodents, and those isolated decades ago, passaged under different laboratory conditions and attenuated to various extents (Table 1). This fact suggested the possibility that the regulation of transcription, which presumably depends on the S motifs, is important for SeV life cycle and ecology.
Previously, several studies with model template systems of various nonsegmented negative-strand RNA viruses indicated that the S signals were indeed critically required for transcriptional initiation but able to tolerate variations in sequence to some extent (1, 2, 18, 25, 36, 40). Certain nucleotide exchanges in their S signals were shown to initiate less transcription, suggesting that gene expression was also modulated by naturally occurring variations in the viral life cycle (26, 27, 39). However, in the model template systems, any event required early in the natural life cycle, like primary transcription, is bypassed by the successive and constant supply of trans-acting proteins (32). The transcription and replication of minigenomes are uncoupled in these systems. T7 polymerase-expressing VV often used to produce the trans-acting proteins might mask the subtle effects of mutations by, for example, the posttranscriptional modifications by VV encoding capping enzyme. In addition, the transfection efficiencies might not be equal throughout the experiment. Thus, to address the roles of S and E signals comprehensively, it has been necessary to introduce relevant mutations into a full-length viral genome (3, 15).
The results obtained here by SeV reverse genetics clearly showed that the S sequence for the F gene was remarkably less potent in initiation than the other three S sequences. That the reduced luciferase gene expression by the F-specific signal was indeed caused primarily at the transcriptional level but was not a secondary result of replication was confirmed by blocking de novo protein synthesis and hence eliminating genome replication (Fig. 2). The primary transcription experiment further assessed that the reinitiation activity driven by the S sequence for the F gene was approximately one fourth those of the other three. These observations are in good agreement with the previous observation that the amounts of N, P, and M mRNAs in SeV-infected cells were almost equally high, but F and HN mRNAs were present in about threefold-lower amounts (17). The results taken together may argue against the view of simple polar attenuation of transcription for SeV, which is essentially linear toward the 5' end of template. Rather, the transcriptional attenuation between the N and P genes as well as that between the P and M genes may be small or negligible. Although the main issue was the steep transcriptional attenuation at the subsequent F gene, the possibility that the low level of mRNA might be the result of the shorter life of the transcripts due to the differences at the S signal could not be ruled out. There is no plausible explanation for the extremely low copy numbers of L mRNA (about 1/30 those of N, P, and M mRNAs) (17). The reinitiation activity of the S sequence for the L gene studied by recombinant simian virus 5 with the reporter green fluorescent protein gene was considerably low (15). The same signal for respiratory syncytial virus (RSV), studied by a model template system, appeared to be as active as the other RSV signals (27). The same was true for SeV as shown here. The contribution of the S signal to L gene expression thus appeared to be variable among the viruses, or the copy number of the extremely long L gene transcripts may be influenced by some other factors, such as processivity of the polymerase.
The reinitiation capacity of different S sequences was then assessed by replacing the natural S sequence of the F gene with that of the P/M/HN genes and by examining the replication capability of the recovered virus (SeV/mSf) in cultured cells, in ovo, and in mice. It was unequivocally demonstrated that the inserted S sequence enhanced F and downstream gene expression, again at the transcriptional level (Fig. 4). The mutant virus with the new S sequence for the F gene replicated faster and was more cytopathic in cultured cells (Fig. 3) and competed out the wild-type virus in eggs (Fig. 5). Thus, the naturally occurring S signal for the F gene appears to moderate the initiation of F gene transcription and viral replication. Since polymerase enters the 3' end of the genome in transcription as well as in replication, once moderated at the F gene, transcription of the downstream genes including the L gene encoding the catalytic subunit of polymerase was also moderated. Then, the next round of both replication and transcription could be affected, ultimately leading to reduced virion RNA synthesis and progeny production.
The in vivo study showed that SeV/mSf had 20 times lower LD50 values and hence was more virulent than the wild type for BALB/c mice (Table 2). CTL generally play a major role in virus clearance by eliminating virus-infected cells. They are also important for immunopathological processes leading to damage of infected cells and tissues. The increased level of F protein expression from the mutant virus would lead to a stronger CTL response. These aspects of CTL appeared to be involved not only in wild-type SeV pathogenesis but also in increased pathogenicity of SeV/mSf as determined by LD50. Thus, the increased pathogenicity of SeV/mSf may simply be attributable to its increased replication capacity.
So far, our data suggest that the F gene S signal imposes a restriction of productive infection on SeV. Its presence in the natural SeV genome did not appear to be advantageous at least in ovo in competition assays with a signal with a higher promoter capacity (Fig. 5). It is therefore quite difficult to conceptualize the basis for the strong conservation of an S sequence with a lower initiation activity at the same position in SeV genomes sequenced to date, including those of highly virulent fresh isolates. One estimate suggested that the LD50 of a fresh isolate is as low as 10 PFU/mouse, whereas that of the egg-adapted strain used here was as high as 105 to 106 PFU/mouse (21, 22, 28). If such a virulent field strain is further potentiated by incorporating an S signal with a higher reinitiation activity into the F gene, infected rodents would be killed so rapidly that they would have less opportunity to transmit virus to new hosts. Indeed, it was recently shown that some newly emerging influenza virus isolates of the H5N1 subtype were too virulent to be transmitted to a neighbor host in a mouse colony (6, 8). Moderation of replication by transcriptional attenuation at the F gene may thus be advantageous for SeV to persist in nature.
RNA-dependent RNA polymerase is error prone (13, 24). The natural S signal for the F gene was here shown to be less advantageous than that with a higher reinitiation activity in hen eggs. Thus, one can predict that SeV with an F start of higher reinitiation capacity would evolve during serial passages in eggs. However, this has not happened over the years, as indicated by strict conservation of the natural F start sequence in all strains sequenced to date. A similar situation is seen for another SeV cis-acting element, the editing motif in the P gene, as it is totally dispensable or even restrictive for viral replication under laboratory conditions but strictly conserved in SeV isolates, including egg-adapted strains (14, 22). These sequence conservations may be somehow required for optimizing replication capacity even in cultured cells and eggs. Alternatively, nucleotide misincorporation may not be equal throughout the genome but is somehow restricted in these regions. Based on this hypothesis, S signal mutation that down-regulates F expression could be beneficial for SeV to persist in nature, since it was fixed early in the evolutionary process and then has been maintained in laboratory strains.
| |
ACKNOWLEDGMENTS |
|---|
We thank D. Kolakofsky and B. Moss for the gifts of pGEM-N, pGEM-P, and pGEM-L and vTF7-3, respectively. The Genome Net services and databases were provided by the Human Genome Center (HGC) at the University of Tokyo.
This work was supported by research grants from the Ministry of Education, Science, Sports and Culture, Japan, and from the Bio-Oriented Technology Research Advancement Institution (BRAIN), Japan.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Viral Infection, Institute of Medical Science, University of Tokyo, Shirokanedai 4-6-1, Minato-ku, Tokyo 108-8639, Japan. Phone: 81-3-5449-5285. Fax: 81-3-5449-5409. E-mail: ynagai{at}ims.u-tokyo.ac.jp.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Barr, J. N., S. P. J. Whelan, and G. W. Wertz. 1997. Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription. J. Virol. 71:1794-1801[Abstract]. |
| 2. | Barr, J. N., S. P. Whelan, and G. W. Wertz. 1997. cis-acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation. J. Virol. 71:8718-8725[Abstract]. |
| 3. |
Bukreyev, A.,
E. Camargo, and P. L. Collins.
1996.
Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene.
J. Virol.
70:6634-6641 |
| 4. | Feldmann, H., E. Muhlberger, A. Randolf, C. Will, M. Kiley, A. Sanchez, and H. D. Klenk. 1992. Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 24:1-19[Medline]. |
| 5. |
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126 |
| 6. |
Gao, P.,
S. Watanabe,
T. Ito,
H. Goto,
K. Wells,
M. McGregor,
A. J. Cooley, and Y. Kawaoka.
1999.
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong.
J. Virol.
73:3184-3189 |
| 7. | Glazier, K., R. Raghow, and D. W. Kingsbury. 1997. Regulation of Sendai virus transcription: evidence for a single promoter in vivo. J. Virol. 21:863-871. |
| 8. | Gubareva, L. V., J. A. McCullers, R. C. Bethell, and R. G. Webster. 1998. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J. Infect. Dis. 178:1592-1596[Medline]. |
| 9. |
Gupta, K. C., and D. W. Kingsbury.
1984.
Complete sequences of the intergenic and mRNA start signals in the Sendai virus genome: homologies with the genome of vesicular stomatitis virus.
Nucleic Acids Res.
12:3829-3841 |
| 10. | Gupta, K. C., and E. Ono. 1997. Stimulation of Sendai virus C' protein synthesis by cycloheximide. Biochem. J. 321:811-818. |
| 11. | Hamaguchi, M., T. Yoshida, K. Nishikawa, H. Naruse, and Y. Nagai. 1983. Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology 128:105-117[Medline]. |
| 12. | Hasan, M. K., A. Kato, T. Shioda, Y. Sakai, D. Yu, and Y. Nagai. 1997. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus. J. Gen. Virol. 78:2813-2820[Abstract]. |
| 13. | Hausmann, S., J. P. Jacques, and D. Kolakofsky. 1996. Paramyxovirus RNA editing and the requirement for hexamer genome length. RNA 2:1033-1045[Abstract]. |
| 14. |
Hausmann, S.,
D. Garcin,
A.-S. Morel, and D. Kolakofsky.
1999.
Two nucleotides immediately upstream of the essential A6G3 slippery sequence modulate the pattern of G insertions during Sendai virus mRNA editing.
J. Virol.
73:343-351 |
| 15. | He, B., R. G. Paterson, C. D. Ward, and R. A. Lamb. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237:249-260[Medline]. |
| 16. | Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59[Medline]. |
| 17. | Homann, H. E., P. H. Hofschneider, and W. J. Neubert. 1990. Sendai virus gene expression in lytically and persistently infected cells. Virology 177:131-140[Medline]. |
| 18. |
Hwang, L. N.,
N. Englund, and A. K. Pattnaik.
1998.
Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions.
J. Virol.
72:1805-1813 |
| 19. | Kato, A., M. Fujino, T. Nakamura, A. Ishihama, and Y. Otaki. 1995. Gene organization of chicken anemia virus. Virology 209:480-488[Medline]. |
| 20. | Kato, A., Y. Sakai, T. Shioda, T. Kondo, M. Nakanishi, and Y. Nagai. 1996. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569-579[Abstract]. |
| 21. | Kato, A., K. Kiyotani, Y. Sakai, T. Yoshida, and Y. Nagai. 1997. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:578-587[Medline]. |
| 22. | Kato, A., K. Kiyotani, Y. Sakai, T. Yoshida, T. Shioda, and Y. Nagai. 1997. Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71:7266-7272[Abstract]. |
| 23. | Kiyotani, K., S. Takao, T. Sakaguchi, and T. Yoshida. 1990. Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology 177:65-74[Medline]. |
| 24. |
Kolakofsky, D.,
T. Pelet,
D. Garcin,
S. Hausmann,
J. Curran, and L. Roux.
1998.
Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.
J. Virol.
72:891-899 |
| 25. | Kuo, L., R. Fearns, and P. L. Collins. 1996. The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. J. Virol. 70:6143-6150[Abstract]. |
| 26. |
Kuo, L.,
H. Grosfeld,
J. Cristina,
M. G. Hill, and P. L. Collins.
1996.
Effect of mutation in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus.
J. Virol.
70:6892-6901 |
| 27. | Kuo, L., R. Fearns, and P. L. Collins. 1997. Analysis of gene start and gene end signals of human respiratory syncytial virus; quasi-templated initiation at position 1 of the encoded mRNA. J. Virol. 71:4944-4953[Abstract]. |
| 28. | Kuronati, A., K. Kiyotani, A. Kato, T. Shioda, Y. Sakai, K. Mizumoto, T. Yoshida, and Y. Nagai. 1998. The paramyxovirus, Sendai virus, C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells 3:111-124[Abstract]. |
| 29. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[Medline]. |
| 30. | Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1204. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven, New York, N.Y. |
| 31. | Luk, D., P. S. Masters, D. S. Gill, and A. K. Banerjee. 1987. Intergenic sequences of the vesicular stomatitis virus genome (New Jersey serotype): evidence for two transcription initiation sites within the L gene. Virology 160:88-94[Medline]. |
| 32. | Nagai, Y. 1999. Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev. Med. Virol. 9:83-99. [Medline] |
| 33. | Nagai, Y., and A. Kato. 1999. Paramyxovirus reverse genetics is coming of age. Microbiol. Immunol. 43:613-624[Medline]. |
| 34. |
Park, K. H., and M. Krystal.
1992.
In vivo model for pseudo-templated transcription in Sendai virus.
J. Virol.
66:7033-7039 |
| 35. |
Paterson, R. G., and R. A. Lamb.
1990.
RNA editing by G-nucleotide insertion in mumps virus P gene mRNA transcripts.
J. Virol.
64:4137-4145 |
| 36. | Rassa, J. C., and G. D. Parks. 1998. Molecular basis for naturally occurring elevated readthrough transcription across the M-F junction of the paramyxovirus SV5. Virology 247:274-286[Medline]. |
| 37. | Sakaguchi, T., K. Kiyotani, A. Kato, M. Asakawa, Y. Fujii, Y. Nagai, and T. Yoshida. 1997. Phosphorylation of the Sendai virus M protein is not essential for virus replication either in vitro or in vivo. Virology 235:360-366[Medline]. |
| 38. |
Shioda, T.,
Y. Hidaka,
T. Kanda,
H. Shibuta,
A. Nomota, and K. Iwasaki.
1983.
Sequence of 3687 nt from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins.
Nucleic Acids Res.
11:7317-7330 |
| 39. | Stillman, E. A., and M. A. Whitt. 1997. Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts. J. Virol. 71:2127-2137[Abstract]. |
| 40. |
Stillman, E. A., and M. A. Whitt.
1998.
The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation.
J. Virol.
72:5565-5572 |
| 41. | Thomas, S. M., R. A. Lamb, and R. G. Paterson. 1988. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54:891-902[Medline]. |
| 42. |
Vidal, S.,
J. Curran, and D. Kolakofsky.
1990.
Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity.
J. Virol.
64:239-246 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»